Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer.
castration resistant prostate cancer
cfRNA
circulating tumor cells
metastatic prostate cancer
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
12 Aug 2021
12 Aug 2021
Historique:
received:
29
07
2021
accepted:
09
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Since tissue material is often lacking in metastatic prostate cancer (mPCa), there is increasing interest in using liquid biopsies for treatment decision and monitoring therapy responses. The purpose of this study was to validate the usefulness of circulating tumor cells (CTCs) and plasma-derived cell-free (cf) RNA as starting material for gene expression analysis through qPCR. CTCs were identified upon prostate-specific membrane antigen and/or cytokeratin positivity after enrichment with ScreenCell (Westford, Massachusetts, USA) filters or the microfluidic Parsortix
Identifiants
pubmed: 34440208
pii: biomedicines9081004
doi: 10.3390/biomedicines9081004
pmc: PMC8391593
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
Nat Rev Clin Oncol. 2014 Jul;11(7):401-12
pubmed: 24821215
N Engl J Med. 2019 Jul 11;381(2):121-131
pubmed: 31157964
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30702443
Prostate Cancer Prostatic Dis. 2016 Sep;19(3):231-41
pubmed: 27184811
Cell Commun Signal. 2020 Jan 24;18(1):11
pubmed: 31980029
J Cell Biochem. 2009 Feb 15;106(3):363-71
pubmed: 19115258
N Engl J Med. 2018 Apr 12;378(15):1408-1418
pubmed: 29420164
Nat Rev Urol. 2012 Aug;9(8):448-63
pubmed: 22777287
Urol Oncol. 1995 Jan-Feb;1(1):18-28
pubmed: 21224086
Eur Urol. 2016 Dec;70(6):985-992
pubmed: 27289566
JAMA Oncol. 2015 Aug;1(5):582-91
pubmed: 26181238
Cancer Res. 2015 Apr 1;75(7):1413-22
pubmed: 25649766
Cancer Res. 2006 Mar 1;66(5):2815-25
pubmed: 16510604
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
Oncogene. 2016 Mar 10;35(10):1216-24
pubmed: 26050619
Clin Chem. 2018 Mar;64(3):536-546
pubmed: 29301749
Clin Chem. 2016 Nov;62(11):1504-1515
pubmed: 27630154
Clin Cancer Res. 2007 Apr 1;13(7):2023-9
pubmed: 17404082
Cells. 2020 Aug 05;9(8):
pubmed: 32764280
Urology. 2012 Dec;80(6):1328-32
pubmed: 23063057
J Clin Oncol. 2016 Apr 20;34(12):1402-18
pubmed: 26903579
Mol Cancer Ther. 2018 Sep;17(9):1833-1845
pubmed: 29891491
Nat Clin Pract Oncol. 2006 Dec;3(12):658-67
pubmed: 17139317
Cancers (Basel). 2020 Jul 28;12(8):
pubmed: 32731472
Oncotarget. 2016 Sep 27;7(39):64447-64470
pubmed: 27487144
Cancer Discov. 2012 Nov;2(11):995-1003
pubmed: 23093251
J Urol. 2020 Jan;203(1):73-82
pubmed: 31389764
Clin Genitourin Cancer. 2018 Dec;16(6):e1133-e1139
pubmed: 30104161
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Res. 2008 Jun 1;68(11):4447-54
pubmed: 18519708
Lancet Oncol. 2009 Mar;10(3):233-9
pubmed: 19213602
Eur Urol. 2020 Aug;78(2):173-180
pubmed: 32487321
Urol Oncol. 2014 Apr;32(3):272-9
pubmed: 24321253
Target Oncol. 2017 Feb;12(1):37-45
pubmed: 27796762
EBioMedicine. 2020 Apr;54:102728
pubmed: 32268276
Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775
pubmed: 27900519
Cancer Res. 2009 Apr 1;69(7):2912-8
pubmed: 19339269
Oncotarget. 2016 Sep 13;7(37):59781-59794
pubmed: 27486973
N Engl J Med. 2020 Sep 10;383(11):1040-1049
pubmed: 32905676
Clin Cancer Res. 2007 Dec 1;13(23):7053-8
pubmed: 18056182
Nat Commun. 2014 Nov 25;5:5548
pubmed: 25420520
Int J Mol Sci. 2016 Aug 04;17(8):
pubmed: 27527157
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Eur J Nucl Med Mol Imaging. 2018 May;45(5):824-845
pubmed: 29234845
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
Clin Genitourin Cancer. 2011 Sep;9(1):31-8
pubmed: 21705286
J Biol Chem. 2004 Mar 12;279(11):10784-95
pubmed: 14672942
Mol Cancer Ther. 2017 Jan;16(1):35-44
pubmed: 27794047
N Engl J Med. 2017 Jul 27;377(4):352-360
pubmed: 28578607
Ann Oncol. 2015 Aug;26(8):1589-604
pubmed: 26041764
J Urol. 2017 Jan;197(1):135-142
pubmed: 27436429